Homepage

The BOSTON-1 and BOSTON-2 are Phase III studies designed to evaluate the safety and efficacy of investigational Liposomal Cyclosporine A (L-CsA-i) in patients with bronchiolitis obliterans syndrome (BOS) following a single or double lung transplant.
Study Overview
Study Overview
Lungs
About BOS
Stethoscope
About Clinical Trials
Locator Icon
Study Centers